Author:
Tsubaki Masanobu,Takeda Tomoya,Yoshizumi Misako,Ueda Emi,Itoh Tatsuki,Imano Motohiro,Satou Takao,Nishida Shozo
Funder
Japan Society for the Promotion of Science (JP)
Ministry of Education, Culture, Sports, Science, and Technology (JP)
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585–98. doi: 10.1038/nrc2189 .
2. Tsubaki M, Satou T, Itoh T, Imano M, Komai M, Nishinobo M, et al. Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells. Leuk Res. 2012;36(10):1315–22. doi: 10.1016/j.leukres.2012.07.003 .
3. Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev. 2001;20(1-2):43–50. doi: 10.1023/A:1013156407224 .
4. Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH, et al. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res. 2003;63(22):7900–6.
5. Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14(9):2519–26. doi: 10.1158/1078-0432.CCR-07-2223 .
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献